Item 7.01  Regulation FD Disclosure
Avanos Medical, Inc. (the "Company") issued a press release on July 12, 2021,
announcing that, effective that same day, Moji James was appointed as Senior
Vice President & General Counsel of the Corporation. A copy of this press
release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated herein by reference.
The information presented in Item 7.01 of this Current Report on Form 8-K and
Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities of that section, unless the Company specifically
states that the information is to be considered "filed" under the Exchange Act
or specifically incorporates it by reference into a filing under the Securities
Act of 1933, as amended, or the Exchange Act.
Item 9.01  Financial Statements and Exhibits
(d)Exhibits.

The following exhibits are filed with this Current Report on Form 8-K:


 Exhibit No.                                  Description
     99.1           Press Release issued by Avanos Medical, Inc. on July 12, 2021
   101.SCH        XBRL Taxonomy Extension Schema Document
   101.CAL        XBRL Taxonomy Extension Calculation Linkbase Document
   101.DEF        XBRL Taxonomy Extension Definition Linkbase Document
   101.LAB        XBRL Taxonomy Extension Label Linkbase Document
   101.PRE        XBRL Taxonomy Extension Presentation Linkbase Document

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses